EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Impact of Pharmacist Board Certification on Health Outcomes of Critically Ill Patients: An Analysis of the Optimizing Pharmacist‐Team Integration for ICU Patient Management ( OPTIM ) Study

Susan E Smith iD, Kelli Henry iD, Mojdeh S Heavner iD, Chelsea Keedy iD, Huong Duong iD, Zhetao Chen iD, XianYan Chen iD, OPTIM Investigator Team, Andrea Sikora iD

JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · 2026-07 · 9 (7)

DOI: 10.1002/jac5.70258 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, online erschienen am 07.07.2026. Verfasst von Susan E Smith und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, University of Georgia, Athens, Georgia, USA. Hauptthemen laut MEDLINE: Pharmacists, Intensive Care Units, Critical Illness, Certification. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: AHRQ HHS, University of Maryland, Baltimore, ASHP Research and Education Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Critical care pharmacists (CCPs) reduce adverse drug events (ADEs) and mortality in the intensive care unit (ICU). Board certification is the established professional standard for CCPs, but its impact on ICU patient outcomes, including its relationship between CCP characteristics and workload, remains unclear. The purpose of this study was to evaluate the association between pharmacist board certification, CCP workload characteristics, and patient outcomes.

Methods

This was a pre‐planned analysis of the multicenter, observational Optimizing Pharmacist‐Team Integration for ICU Patient Management (OPTIM) study including adult ICU patients cared for by CCPs. Patients cared for exclusively by board‐certified pharmacists on every ICU day were categorized as the BCP group; those with at least 1 day of care from a non‐board‐certified pharmacist comprised the non‐BCP group. The primary outcome was hospital mortality; secondary outcomes included the hazard of discharge alive (HDA) from the ICU and hospital. Multivariable logistic regression was used to evaluate the association between BCP and mortality; Fine‐Gray competing risk models were used to assess the relationship between BCP and ICU and hospital HDA.

Results

In total, 201 pharmacists (184 BCPs; 17 non‐BCPs) from 63 institutions caring for 20 537 ICU patients were included. Care provided exclusively by a BCP (vs ≥ 1 day by a non‐BCP) was associated with lower mortality (odds ratio [OR] 0.80, 95% confidence interval [CI] 0.69–0.92, p = 0.002) and both a higher ICU HDA (hazard ratio [HR] 1.08, 95% CI 1.03–1.13, p < 0.001) and hospital HDA (HR 1.19, 95% CI 1.13–1.26, p < 0.001).

Conclusion

Daily ICU care delivered by pharmacists with board certification was independently associated with reduced mortality and improved HDA from the ICU. Board‐certified pharmacists may enhance the quality and/or efficiency of critical care pharmacy services. These findings support the role of board certification as a modifiable factor to improve patient outcomes and optimize workload in the ICU.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PharmacistsIntensive Care UnitsCritical IllnessCertificationPharmacy Service, HospitalPatient Care TeamCritical CareHumansFemaleHospital MortalityMaleMiddle AgedAgedWorkloadProfessional Role

Stichwörter der Autor:innen

certificationcritical carelength of staymortalitypatientpharmacistsworkload

Autor:innen und Institutionen

  • College of Pharmacy, University of Georgia, Athens, Georgia, USA.
  • School of Medicine, University of Colorado, Aurora, Colorado, USA.
  • School of Pharmacy, University of Maryland, Baltimore, Maryland, USA.
  • College of Pharmacy, University of Georgia, Savannah, Georgia, USA.
  • College of Public Health, University of Georgia, Athens, Georgia, USA.

ORCID-Profile: Susan E Smith, Kelli Henry, Mojdeh S Heavner, Chelsea Keedy, Huong Duong, Zhetao Chen, XianYan Chen, Andrea Sikora

Förderung

  • AHRQ HHS
  • University of Maryland, Baltimore
  • ASHP Research and Education Foundation
  • Board of Pharmacy Specialties
  • ACCP Critical Care PRN
  • NCATS NIH HHS
  • Agency for Healthcare Research and Quality
  • National Center for Advancing Translational Sciences

Zitieren

APA

Smith, S. E., Henry, K., Heavner, M. S., Keedy, C., Duong, H., Chen, Z., Chen, X., OPTIM Investigator Team, & Sikora, A. (2026). Impact of Pharmacist Board Certification on Health Outcomes of Critically Ill Patients: An Analysis of the Optimizing Pharmacist‐Team Integration for ICU Patient Management ( OPTIM ) Study. JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, 9(7). https://doi.org/10.1002/jac5.70258

Vancouver

Smith SE, Henry K, Heavner MS, Keedy C, Duong H, Chen Z, et al. Impact of Pharmacist Board Certification on Health Outcomes of Critically Ill Patients: An Analysis of the Optimizing Pharmacist‐Team Integration for ICU Patient Management ( OPTIM ) Study. JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 2026;9(7). doi:10.1002/jac5.70258

BibTeX
@article{Smith2026,
  author = {Smith, Susan E and Henry, Kelli and Heavner, Mojdeh S and Keedy, Chelsea and Duong, Huong and Chen, Zhetao and Chen, XianYan and OPTIM Investigator Team, OPTIM Investigator Team and Sikora, Andrea},
  title = {Impact of Pharmacist Board Certification on Health Outcomes of Critically Ill Patients: An Analysis of the Optimizing Pharmacist‐Team Integration for ICU Patient Management ( OPTIM ) Study},
  journal = {JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY},
  year = {2026},
  volume = {9},
  number = {7},
  doi = {10.1002/jac5.70258}
}
Kostenlos starten →